Astellas/Pfizer Settle Dispute Over Lipitor Rights In Japan
Firms also gain Japanese marketing approval for celecoxib for treatment of inflammation and pain associated with rheumatoid arthritis and osteoarthritis.
Firms also gain Japanese marketing approval for celecoxib for treatment of inflammation and pain associated with rheumatoid arthritis and osteoarthritis.